This publication is a second review of the Swiss Health System and is an update on the review carried out in 2006.
The Swiss health system is one of the world’s best but must adapt to deal with rising costs and higher rates of cancer, cardiovascular disease and diabetes, according to a new OECD/WHO report.
This book examines international drivers, enabling technologies fast-tracking industrial biotechnology, industry trends, some products appearing on the market, industry structure and finance, and policy measures and trends. It examines separately biofuels, biobased chemicals and bioplastics.
This report provides an update to the information and analysis presented in the Review of the Swiss Health System published by the OECD and the WHO in 2006, with a particular focus on three issues: health workforce, health insurance markets and governance of the Swiss health system.
English, , 615kb
Despite the high-profile media interest and coverage, there is a lack of hard research evidence on the role and impact of medical tourism for OECD countries.
Medical tourism is apparently growing rapidly and yet there is little data on the extent of the provision of health care services across borders. This OECD paper identifies the key emerging policy issues relating to the rise in this new market.
English, , 768kb
This report discusses ways in which both the public and private sectors are seeking to evolve from an “own and protect” model of intellectual property into an era of “own and share”, where value accrues not just to the initial owner of IP, but also to larger society as a whole.
This report reviews the impact of pay increases on nurses’ labour market in four countries (UK, New Zealand, Finland and Czech Republic). Pay increases contributed to an increase in potential new entrants to nurse education, but the effect on nurses already in work is more difficult to assess.
Health spending continues to rise faster than economic growth in most OECD countries, maintaining a trend observed since the 1970s. Health spending reached 9.5% of GDP on average in 2009, the most recent year for which figures are available, up from 8.8% in 2008, according to OECD Health Data 2011.
The Recommendation seeks to assist both OECD member and non-member countries in the development of appropriate sustainability assessment methodologies for bio-based products.